Month: September 2022

Press Release – Intelehealth awarded at the HDFC Parivartan SmartUp Grants 2022

Intelehealth awarded at the HDFC Parivartan SmartUp Grants 2022

Intelehealth has been chosen as one of the top 85 grantees of the HDFC Parivartan SmartUp Grants 2022 for its innovative and high-impact solutions to key challenges in Indian healthcare.

Intelehealth, a tech-for-impact organization was recently named the 5th annual HDFC Parivartan SmartUp Grants 2022 winner. Along with Intelehealth, HDFC bank awarded grants to 85 other innovative start-ups from a pool of over 150 applicants from across the country working in various sectors. The grants were awarded following a rigorous screening process that focused on addressing environmental, healthcare, and gender diversity issues.

These grants received will help Intelehealth to expand its reach in rural India, launch new telemedicine projects, and develop and strengthen technology that aims to bridge the gap between rural populations and healthcare providers. 

Neha Verma – CEO & Co-Founder, Intelehealth: “We would like to thank the HDFC Parivartan SmartUp Grants 2022 team for recognizing and believing in our work and awarding us the grant. This grant money will be extremely beneficial in assisting us in meeting our current objectives. With this grant, the organization will expand and scale up the Telemedicine projects in areas where access to healthcare remains a barrier. We look forward to this valuable partnership and are grateful for your belief in the mission that we strive for”.

These grants are intended to support startups that provide one-of-a-kind solutions to bring about long-term change in society and the environment. The grants were made available through Parivartan, the HDFC bank’s flagship CSR program for social initiatives. 

About Inteleheath : Intelehealth is a tech-for-impact organization: A team of engineers, clinicians, management and public health experts. We’ve developed an innovative open source telemedicine platform connecting the last mile population with affordable and quality healthcare services. 

Our mission is to “Deliver quality healthcare where there is no doctor”. 

Our vision is “Health for all”, we believe in the vision of universal health coverage – that you should be able to receive the health services you need, when and where you need them, without facing financial hardship.

 To know more about Intelehealth, log on to www.intelehealth.org 

For more information, kindly contact : 

Nishant Pratap Singh – Director, Partnership (nishant@intelehealth.org)

Rhea Mathews Manager – Marketing & Communications (rhea@intelehealth.org)

Other Blogs

We look forward to partnering with you

Together we can make telemedicine reach the last mile

Contact Us

Press Release – Intelehealth partners with ACT to deploy eSanjeevani in Odisha

Intelehealth partners with ACT for the deployment of eSanjeevani in Odisha

Intelehealth receives a grant from ACT which will be used to enhance the eSanjeevani telemedicine program in the state of Odisha in partnership with the National Health Mission.

Intelehealth has collaborated with ACT for the implementation of the eSanjeevani Telemedicine programme across the state of Odisha’s Health & Wellness Centres (HWCs), Primary Health Centres (PHCs), and Urban
Primary Health Centres (UPHCs).

The implementation of the national telemedicine programme in Odisha aims to promote comprehensive primary health care while also strengthening systems by making them more resilient and accessible. This project will benefit 1,600 health care facilities in 30 districts.

Neha Verma – CEO & Co-Founder, Intelehealth: “We would like to thank ACT Grants for recognizing and believing in our work and awarding us the grant. This grant money will be extremely beneficial in assisting us in meeting our current objectives. With your support, the organization will deploy eSanjeevani in the remotest parts of Odisha where access to healthcare remains a barrier. We look forward to this valuable partnership and are grateful for your belief in the mission that we strive for”.

Intelehealth aims to improve capacity building, and skill development for the frontline health workforce and mobilize the community to create and increase awareness of the eSanjeevani telemedicine program in the state of Odisha.

About Inteleheath :
Intelehealth is a tech-for-impact organization: A team of engineers, clinicians, management and public health experts. We’ve developed an innovative open source telemedicine platform connecting the last mile population with affordable and quality healthcare services.


Our mission is to “Deliver quality healthcare where there is no doctor”.

Our vision is “Health for all”, we believe in the vision of universal health coverage – that you should be able to receive the health services you need, when and where you need them, without facing financial hardship.


To know more about Intelehealth, log on to www.intelehealth.org


For more information, kindly contact :


Nishant Pratap Singh – Director, Partnership (nishant@intelehealth.org)


Rhea Mathews – Manager, Marketing & Communications (rhea@intelehealth.org)

Other Blogs

We look forward to partnering with you

Together we can make telemedicine reach the last mile

Contact Us

Press Release – Intelehealth joins Digital Public Goods Alliance

PRESS RELEASE

Advancing 'Health for All' through Telemedicine: Intelehealth joins Digital Public Goods Alliance

July 04, 2022: Intelehealth was added to the Digital Public Goods Alliance DPG Registry last week. This underscores Intelehealth’s commitment to developing and championing digital public goods that will help achieve ‘Health for All’ and contribute to the Sustainable Development Goals (SDGs). 

Intelehealth is a non-profit delivering high-quality healthcare for the last -mile population where there is no doctor through telemedicine. Using our open-source technology platform that’s driven by an innovative digital health assistant, we connect patients and frontline health workers at the last mile with qualified doctors, diagnostics & medications. Intelehealth is on track to provide healthcare for 10 million women over the next three years in partnership with Ministries of Health in India & Kyrgyzstan. Intelehealth has been recognized by the World Economic Forum, UNICEF, and NITI Aayog as an impactful Digital Public Good. 

Our mission is to “Deliver quality healthcare where there is no doctor through Telemedicine” 

Our vision is “Health for all” we believe in the vision of universal health coverage – that you should be able to receive the health services you need, when and where you need them, without facing financial hardship. 

For us, being recognized as a digital public good – defined as open source software, available data, open AI models, open standards and content that adhere to privacy and other applicable laws and best practices- does no harm and help attain the SDGs. 

“Intelehealth’s addition to the DGP registry recognizes its commitment to providing high-quality healthcare for last-mile populations where there is no doctor through Telemedicine and for closing the digital divide between urban and rural populations by providing affordable access to healthcare using our digital public good platform”, said Intelehealth CEO & Co-founder, Dr. Neha Verma. 

The Digital Public Goods Alliance is a multi-stakeholder initiative endorsed by the United Nations Secretary-General, working to accelerate the attainment of the Sustainable Development Goals in low- and middle-income countries by facilitating the discovery, development, use of, and investment in digital public goods. 

To know more about Intelehealth, log on to www.intelehealth.org For more information, kindly contact : 

Nishant Pratap Singh – Director, Partnerships (nishant@intelehealth.org)

Rhea Mathews – Manager, Marketing & Communications (rhea@intelehealth.org)

Other Blogs

We look forward to partnering with you

Together we can make telemedicine reach the last mile

Contact Us

We look forward to partnering with you

Together we can make telemedicine reach the last mile

Contact Us

India is home to 77 million diabetics, second highest in the world : Is Telemedicine a solution?

Diabetes is one of this century’s most significant global health emergencies, ranking among the ten leading causes of mortality and cardiovascular disease (CVD), respiratory disease, and cancer. According to the World Health Organization (WHO), non-communicable diseases (NCDs) accounted for 74% of deaths globally in 2019, of which Diabetes resulted in 1.6 million deaths, thus becoming the ninth leading cause of death globally.

[Data source WHO   https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/ncd-mortality]

According to ICMR’s guidelines, India is home to the world’s second-largest adult diabetes population, and every sixth person with Diabetes in the world is an Indian. The past three decades witnessed a 150 percent increase in the number of people with Diabetes in the country. The progressive lowering of the age at which type 2 diabetes is being diagnosed, with the disease prevalence becoming apparent in the age group of 25-34 years in both urban and rural areas.

[Data Source ICMR https://main.icmr.nic.in/sites/default/files/upload_documents/ICMR_Guidelines_for_Management_of_Type_1_Diabetes.pdf]

Causes of Diabetes

  • Multifactorial pathogenesis in which metabolic, behavioral, lifestyle and environmental factors precipitate disease in genetically predisposed persons
  • The combination of insulin resistance increased hepatic gluconeogenesis, and relative defects in insulin secretion promote metabolic dysfunction.
  • Overweight or obese body habitus is a significant factor contributing to insulin resistance, which is a precursor to glucose intolerance and diabetes development.
  • A hypercaloric diet and sedentary lifestyle also worsen insulin resistance
  • Hyperglycemia develops when progressive impairments in insulin secretion render pancreatic β-cells unable to maintain euglycemia
  • Vital hereditary component contributes to the manifestation of the disease, with complex polygenic inheritance pattern underlying most cases

Risk factors of Diabetes

Age
  • Incidence increases with age, owing in part to age-related reduced glucose tolerance but also reduced physical activity and increased adiposity
Gender: Women with a history of the following are at greater risk for diabetes:
  • Polycystic ovary syndrome (PCOS)
  • Delivery of an infant weighing more than 4 kg
  • Previous diagnosis of gestational diabetes (Diabetes during pregnancy)
Genetics
  • Most cases of type 2 diabetes have a complex multifactorial polygenic basis, with over 100 loci identified as contributing to a higher risk.
  • Genetic risk for type 2 diabetes is primarily expressed in environmental factors such as obesity and a sedentary lifestyle.
Ethnicity/race
  • Increased prevalence in African American, Latino, Native American, Pacific Islander, and Asian American populations
 Other risk factors/associations
  • Prediabetes (hemoglobin A1C level (HbA1C) 7%-6.4%; 5-fold elevated risk)
    • Overweight or obesity (2-fold elevated risk if overweight; risk rises proportionately with a higher class of obesity)
    • Sedentary lifestyle
    • Medications that worsen glucose tolerance or exacerbate hyperglycemia, such as:
      •  GlucocorticoidsThiazide diuretics
      • Atypical antipsychotics
      • Sleep disorders (eg, obstructive sleep apnea, chronic sleep deprivation, night shift work schedule) in conjunction with glucose intolerance

    What is Type 1 Diabetes?

    Type 1 diabetes (previously known as insulin-dependent, juvenile, or childhood-onset) is characterized by low insulin production and requires daily administration of insulin. In 2017 there were 9 million people with type 1 diabetes; most of them live in high-income countries. Neither its cause nor the means to prevent it are known. Symptoms include excessive excretion of urine (polyuria), thirst (polydipsia), constant hunger, weight loss, vision changes, and fatigue. These symptoms may occur suddenly.

    What is type 2 Diabetes?

    Type 2 diabetes (formerly called non-insulin-dependent or adult-onset) results from the body’s ineffective use of insulin. More than 95% of people with Diabetes have type 2 diabetes. This type of Diabetes is primarily the result of excess body weight and physical inactivity. Symptoms may be similar to type 1 diabetes but are often less marked. As a result, the disease may be diagnosed several years after onset, after complications have already arisen. Until recently, this type of Diabetes was seen only in adults, but it is now also occurring increasingly frequently in children.

    Prevention

    Simple lifestyle measures are effective in preventing or delaying the onset of type 2 diabetes. To help prevent type 2 diabetes and its complications, people should:
    • Achieve and maintain healthy body weight;
    • Be physically active – doing at least 30 minutes of regular, moderate-intensity activity on most days. More activity is required for weight control;
    • Eat a healthy diet, avoid sugar and saturated fats; and
    • Avoid tobacco use – smoking increases the risk of Diabetes and cardiovascular disease.

    Diagnosis and treatment

    • Early diagnosis can be accomplished through relatively inexpensive testing of blood sugar.
    • Treatment of Diabetes involves diet and physical activity along with lowering blood glucose and the levels of other known risk factors that damage blood vessels. Tobacco use cessation is also important to avoid complications.
    • Interventions that are both cost-saving and feasible in low- and middle-income countries include blood glucose control, particularly in type 1 diabetes. People with type 1 diabetes require insulin. People with type 2 diabetes can be treated with oral medication but may also require insulin, blood pressure control, and foot care (patient self-care by maintaining foot hygiene; wearing appropriate footwear; seeking professional care for ulcer management; and regular examination of feet by health professionals).
    Other cost-saving interventions include screening and treatment for retinopathy (which causes blindness), blood lipid control (to regulate cholesterol levels), and screening for early signs of diabetes-related kidney disease and treatment. [Data source – WHO https://www.who.int/news-room/fact-sheets/detail/diabetes)

    Intelehealth and MSF India Response

    Diabetes is rising in India, with the second-highest diabetics due to increased sedentary lifestyles, unhealthy diets, tobacco use, and obesity. Nearly 50% of the population are unaware that they have Diabetes. Intimidated by the stats showing India has the second highest number of diabetics in the world, MSF India launched the telemedicine Diabetic Management Helpline, powered by Intelehealth, to provide primary-level diabetes care and manage the disease and encourage healthy living. A pan-India toll-free helpline would improve access to standardized and uniform helpful information about diabetes care which would be customized to their needs. This would significantly help the underprivileged, who would otherwise postpone or even forgo needed healthcare due to non-affordability. Such digital technology platforms motivate the patients for diabetes self-management through constant follow-ups, counseling and access to a diet plan. The helpline would allow the patients to seek consultations at their convenience. By providing appropriate counseling on healthy meal plans and lifestyle modifications by an accredited dietician, increasing awareness, and promoting self-monitoring of health and routine follow-ups, the helpline could minimize the risks of future complications.  Additionally, the helpline would also support the patients in seeking psychological healthcare, which is crucial to the overall management of Diabetes, without the fear of stigmatization. If you have Diabetes and need medical assistance, contact the Diabetic Management Helpline. Call 1800 309 4144 and connect with a team of nurses, doctors & nutritionists and learn how to manage your diabetes effectively.

References:
1. Dluhy RG et al: Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 358(24):2630-3, 2008

2. Tancredi M et al: Excess mortality among persons with type 2 diabetes. N Engl J Med. 373(18):1720-32, 2015

3. Skyler JS et al: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 53(3):298-304, 2009

4. Riddle MC et al: Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. ePub, 2021

5. Nathan DM: Diabetes: advances in diagnosis and treatment. JAMA. 314(10):1052-62, 2015

6. Bonnefond A et al: Rare and common genetic events in type 2 diabetes: what should biologists know? Cell Metab. 21(3):357-68, 2015

7. American Diabetes Association Professional Practice Committee et al: 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 45(Supplement_1):S17-38, 2022

8. Selvin E et al: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 362(9):800-11, 2010

9. Nguyen NT et al: Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006. Obes Surg. 21(3):351-5, 2011

10. Telemedicine Cost–Effectiveness for Diabetes Management: A Systematic Review:Jun Yang Lee and Shaun Wen Huey Lee

11. Telemedicine Application in the Care of Diabetes Patients: Systematic Review and Meta-Analysis : Milena Soriano Marcolino, Junia Xavier Maia, Maria Beatriz Moreira Alkmim, Eric Boersma, Antonio Luiz Ribeiro

Other Blogs

We look forward to partnering with you

Together we can make telemedicine reach the last mile

Contact Us